
About Merck Life Science Private Limited
Data last updated:
Merck Life Science Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Sigma-Aldrich Pte Limited, Singapore. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 September 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33100MH1986PTC221693. Its GSTIN is 27AACCM1226B1Z4 (Maharashtra). The company holds 14 GST registrations, of which 10 are active.
The company has an authorised share capital of ₹2.25 Cr and a paid-up capital of ₹2.22 Cr. It was formerly known as Millipore (India) Limited and Millipore Asia Limited. It is led by directors Dhananjay Singh (Managing Director) and Pankaj Kumar Joshi.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Godrej One 8th Floor Pirojshanagar Eastern Express Highway Vikhroli – East, Mumbai, Maharashtra, India – 400079.
As per the financials filed for FY 2025, the company reported a revenue of ₹2,200.06 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹127.97 Cr (net margin 5.8%) and EBITDA of ₹229.32 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 13% over five years.
The company has about 618 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Merck. As per MCA filings, the company has open charges of ₹27.3 Cr on record. Court records list 107 cases involving the company, including 63 filed by the company and 44 filed against it; 13 cases are pending. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2019. The company has 21 MSME Form 1 returns on record between 2015 and 2024, listing 247 overdue payments to 77 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website merckgroup.com.
Company details
Name history
Merck Life Science has undergone 3 name changes throughout its history. The company was previously known as Millipore (India) Limited, Millipore Asia Limited, and Millipore (India) Private Limited. The current legal name is Merck Life Science Private Limited.
| Company Name | Status |
|---|---|
| Merck Life Science Private Limited | Current |
| Millipore (India) Limited | Previous |
| Millipore Asia Limited | Previous |
| Millipore (India) Private Limited | Previous |
CIN history
Merck Life Science has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U33100MH1986PTC221693, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33100MH1986PTC221693 | Current |
| U33100KA1986PTC007759 | Previous |
| U85110KA1986PTC007759 | Previous |
Contact details
Merck Life Science Private Limited's registered office is in Mumbai, Maharashtra. Its website is merckgroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGodrej One 8th Floor Pirojshanagar Eastern Express Highway Vikhroli – East, Mumbai, Maharashtra, India – 400079
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Merck Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Merck Life Science operates one associated brand: Merck. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Merck is engaged in science and technology solutions globally. | merckgroup.com |
Business activity
The main business activities of Merck Life Science are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Merck Life Science Private Limited, buy the company report.
Financials of Merck Life Science Private Limited
FY 2025 filings availableMerck Life Science Private Limited reported revenue of ₹2,200.06 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 7% growth in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2,200.06 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹229.32 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹127.97 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Merck Life Science Private Limited, buy the company report.
Board of directors of Merck Life Science Private Limited
Merck Life Science has 2 current directors and 28 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Kumar Joshi | Additional Director | 30 Jan 2026 | 0 Years 9 Months | Current |
| Dhananjay Singh Also directs: Sigma Aldrich Chemicals Private Limited | Managing Director | 01 Apr 2024 | 2 Years 7 Months | Current |
Auditor
Merck Life Science Private Limited is audited by B S R & Co Llp for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co Llp | FY 2023 | 101248W/W-100022 |
Shareholding
The shareholding of Merck Life Science Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Merck Life Science Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jul 1997 | 90194100 | State Bank of India | ₹24 Cr | Open | |
| 26 Jul 1993 | 90193733 | State Bank of India | ₹1.2 Cr | Open | |
| 24 Dec 1990 | 90193570 | Canara Bank | ₹1 Cr | Open | |
| 24 Feb 1990 | 90193520 | Canara Bank | ₹1 Cr | Open | |
| 08 Jul 1989 | 90193474 | Canara Bank | ₹10 Lakh | Open |
To see the full charge records of Merck Life Science Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Merck Life Science Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2019.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2019 | Rights issue | ₹346.82 Cr | Investors: Sigma Aldrich Pte Limited, Merck Life Science Private Limited |
| Dec 2017 | Rights issue | ₹423.41 Cr | Investors: Sigma Aldrich Pte Limited, Merck Life Science Private Limited Seller: Millioore Mauritius Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: Millioore Mauritius Limited Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Merck Life Science Private Limited has 107 court cases on record: 63 filed by Merck Life Science, 44 filed against it. 13 cases are pending and 94 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 74 | 36 | 6 |
| District courts | 31 | 8 | 7 |
| Supreme Court | 1 | 0 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 107)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against Teknirvana Trade Links Pvt. Ltd. | Pending |
| NCLT, Mumbai | Insolvency matter | Filed by the company against Wockhardt Limited | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by Wockhardt Ltd. | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Wockhardt Ltd. | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMARY CIVIL SUIT) | Filed against the company by Toshvin Analytical Pvt Ltd | Disposed |
To see the full case history of Merck Life Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Merck Life Science Private Limited has 21 MSME Form 1 returns on record between 2015 and 2024, listing 247 overdue payments to 77 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 77)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Aleph Accreditation and Testing Centre Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Merck Life Science Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Merck Life Science Private Limited has a workforce of 618 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
GST
Merck Life Science has 14 GST registrations: 10 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCM1226B1Z4 | Maharashtra | Active | 01 Jul 2017 |
| 27AACCM1226B3Z2 | Maharashtra | Active | 10 Nov 2017 |
| 07AACCM1226B2Z5 | Delhi | Active | 01 Jul 2017 |
| 19AACCM1226B1Z1 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Merck Life Science Private Limited, buy the company report.
Recent activity
Merck Life Science Private Limited has 29 board changes on record since 2007: 2 appointments and 27 cessations. The latest: Pankaj Kumar Joshi was appointed as Additional Director on 30 Jan 2026.
28 earlier events are in the company report.
News
Frequently asked questions
Merck Life Science is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 September 1986 (40+ years old) and is registered under CIN U33100MH1986PTC221693.
Merck Life Science has 2 current directors:
- Dhananjay Singh - Managing Director
- Pankaj Kumar Joshi - Additional Director
The latest financial statements of Merck Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Merck Life Science is 27AACCM1226B1Z4, registered in Maharashtra. The company has 14 GST registrations in all, of which 10 are active and 4 are cancelled or inactive. Other active GSTINs include 27AACCM1226B3Z2 (Maharashtra), 07AACCM1226B2Z5 (Delhi), 19AACCM1226B1Z1 (West Bengal).
The CIN (Corporate Identification Number) of Merck Life Science is U33100MH1986PTC221693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Merck Life Science has 107 court cases on record: 63 filed by the company and 44 filed against it. 13 are pending. Most are in the high courts.
Merck Life Science was incorporated on 03 September 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Merck Life Science has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2019.
Pankaj Kumar Joshi was appointed as Additional Director on 30 Jan 2026. Dhananjay Singh was appointed as Managing Director on 01 Apr 2024. Dhananjay Singh ceased to be Additional Director on 01 Apr 2024. Merck Life Science has 29 board changes on record in total.
Merck Life Science has 21 MSME Form 1 returns on record between 2015 and 2024, listing 247 overdue payments to 77 micro and small suppliers. The latest return was filed on 23 Apr 2024.
Merck Life Science can be reached through the website merckgroup.com. Its registered office is in Mumbai, Maharashtra, India.

